What is CheckEye?
AI-driven platform for mass screening of chronic diseases to enable preventive healthcare for everyone around the world
Problem
According to the World Health Organization, chronic diseases such as cardiovascular diseases, cancer, chronic respiratory diseases, and diabetes are the leading causes of death globally, responsible for over 70% of all deaths. This equates to 41 million people each year, with 15 million of these deaths occurring prematurely, between the ages of 30 and 69.
āChronic diseases are a global challenge, but through prevention, early detection, and timely treatment, millions of lives can be savedā
– WHO
The World Health Organisation defines diabetic retinopathy as the leading cause of blindness in the working age population in most countries. However, early diagnosis and timely treatment of diabetic retinopathy can prevent sight impairment and blindness. Interventions that are both cost-saving and feasible include screening and treatment for retinopathy.
approximately 2% of people become blind,
and about 10% develop severe visual impairment.ā
– World Health Organisation
Solution
CheckEye has developed a cloud-based solution to detect a wide range of chronic diseases, including diabetic retinopathy, using photographic images of the eye fundus through advanced ML/AI algorithms. These photographs can be taken anywhere, from optical retailers to pharmacies, by non-medical staff and then uploaded to the system for diagnosis. CheckEye makes early detection and prevention of chronic diseases, including diabetic retinopathy, accessible to everyone
Who benefits?
The public health and economic benefits of early detection, prevention, and treatment of chronic diseases, including diabetic retinopathy, are immense
PATIENTS
REDUCED WAITING TIME
Reduced waiting time to access professional treatment by receiving quick and accurate retinopathy screening test results in a wide network of locations.
BETTER COST EFFICIENCY
More cost-effective treatment of chronic diseases
TIMELY TREATMENT
Early detection and timely treatment of chronic diseases improve health outcomes and reduce costs
BETTER VISION FOR LIFE
Mitigate the risk of developing severe cases of chronic diseases, including retinopathy and blindness
EYE HEALTH PROFESSIONALS
MORE QUALITY TIME WITH PATIENTS
Mobile screening for chronic diseases increases the efficiency of specialists by freeing up time spent on routine screenings, allowing them to focus on more complex cases
ACCURATE DIAGNOSIS
More accurate diagnosis through better quality of screening images achieved with AI-based technology
BETTER PERFORMANCE RESULTS
Higher rate of appointments for patients with screen-positive results who require treatment more urgently.
PUBLIC HEALTH SYSTEMS & INSURANCE COMPANIES
BETTER ACCESS TO SCREENING
Lowering the barriers to access and reducing the cost of systematic chronic disease screening tests help to decrease the disease burden on public health and social care systems
LESS FINANCIAL BURDEN
Early detection of chronic diseases significantly reduces treatment costs by preventing complications and the need for more intensive care
MORE ACCURATE SCREENING RESULTS
Automated image analysis systems provide a more accurate diagnosis compared to the manual grading, thus allowing to prioritise patients for treatment based on the severity of their condition.
LESS ADMIN WORK FOR MEDICAL PERSONNEL
Where there are staff shortages and/or limited access to treatments, the system prioritises patients automatically based on the severity of their condition.
Our team
CheckEye operates an international team based in the UK, Ukraine and Switzerland. Our shared credentials include decades of senior level experience across IT, telecom and health industries in global brands, higher education in the world’s best universities, and a profound understanding of the rapidly evolving healthcare trends globally.
Kirill Goncharuk,
CEO
Kirill is a senior IT professional with two decades of technology and IT product development experience. His role at CheckEye encompasses both general management and product development, underpinned by expertise gained across Kirillās work in large corporates in information technology & security and business continuity roles across industries – energy, system integration and telecom. Kirill has been on the senior leadership teams in Ukraineās largest names such as VEON, DTEK, and currently Ukrtelecom.
Kirill is a candidate for Global Executive MBA from IESE Business School, University of Navarra.
Dmitry Sofyna,Ā
CTO
Dmitry is the head of the Artificial Intelligence Research and Development Center. He has over 10 years of experience in analyzing business needs and developing digital solutions. Prior to this, he worked in the field of finance and banking. He holds two higher education degrees. He is the founder and Chairman of the Supervisory Board of the Vinnytsia IT Association. He is also the founder of the UME ecosystem for learning and work. He is the author of the Country’s Digital Transformation concept.
Andrii Korol,
Medical AdvisorĀ
Andrii is a Doctor of Medical Sciences, Senior Researcher, Head of the Department of Studying the Biological Action and Application of Lasers in Ophthalmology of the āThe Filatov Institute of Eye Diseases and Tissue Therapy of the National Academy of Medical Sciences of Ukraineā, specialisation in ophthalmology: diagnosis of fundus diseases, laser microsurgery, treatment of fundus diseases using antiangiogenic factors. Author of 39 scientific articles in international journals included in the Scopus scientometric database, two monographs, scientific supervisor of three dissertations.
Member of the Ukrainian Society of Ophthalmologists, European Society of Retina Specialists –Ā EURETINA, International Expert Group of Vision Academy.
Michael Shuranov, Communications Advisor
Michael is a senior communications professional bringing over 20 years of hands-on experience in public relations and reputation management. Having worked in senior communications roles in large corporates across food, retail and telecom including McDonaldās, Avon, VEON and currently Ukrtelecom, the largest telco in Ukraine, Michael advises CheckEye on the high level strategic positioning and comm steam design.
Michael teaches Media Relations at the Chartered Institute of Public Relations, Ukraine.
Daria Partas,
Head of Communications
Daria is a London-based strategic communications advisor and reputation management expert with over 15 years of experience. Daria’s career includes working in communication roles in/with complex matrix cross-border organisations such as BT, VEON, United Nations, and CNN International. With over 15 years of experience in international communications, she is responsible for developing the brand vision, core positioning and global communications strategies for CheckEye.
Daria graduated with an MA in Digital Culture and Society from Kingās College London. She holds a CIPR Professional PR Diploma from Londonās PR Academy and a Certificate in Analyst Relations from Forrester.
News
“Smart” Insulin: The future of treatment for people with Type 1 Diabetes
Scientists around the world are approaching a significant breakthrough in the treatment of type 1 diabetes. Insulin that responds to blood sugar levels in real-time could become the new standard of care for millions of people. This "smart" insulin, which activates...
The Ukrainian medical screening platform CheckEye, built on AI technology, has begun operating in Germany
The Ukrainian medical platform CheckEye, which detects signs of diabetic retinopathy using artificial intelligence (AI), has become part of Gesundheitskiosk24 by Aspilos GmbH. This innovative concept provides health status checks, such as blood analysis or vitamin...
Why do low income and education increase the risk of diabetes?
Health inequality related to non-communicable diseases remains relevant across various socio-economic strata. Research indicates that individuals with low socio-economic status (SES) are at higher risk of mortality from metabolic syndrome, type 2 diabetes, and...
CheckEye receives grant from WNISEF and Ukrainian Startup Fund
We are pleased to announce that CheckEye has been awarded financial support from the Ukraine-Moldova American Enterprise Fund (WNISEF) and the Ukrainian Startup Fund. This achievement marks a significant milestone for our organization and validates our dedication to...
How are glucose and blood pressure fluctuations linked to retinopathy, and what role does their control play?
Glucose serves as a vital energy source for our bodies, but it needs to be maintained within normal levels to prevent serious complications. One such complication is retinopathy, resulting from damage to the eye's retina capillaries. Controlling blood glucose levels...
Beyond the battlefield. Fighting on the diabetic frontline
Diabetes strikes veterans, too! Recent research underscores a troubling reality: the prevalence of diabetes among military personnel is significantly higher than that of the general population. A study conducted by a team of scientists from the University of Tennessee...
Unforgettable impressions fromĀ TechChillĀ 2024!
This year, we had the honor of representing #Ukraine at one of the most significant tech events in the Baltics ā TechChill 2024! š±š»It was an incredible opportunity to meet over 2300 participants from 40 countries around the world, including 600 startups, 250...
The sharp edge of diabetes begins when it’s still undetected!
In today's world, diabetes is becoming increasingly noticeable, but the most concerning scenario is undiagnosed diabetes ā a silent hijacker of health, waiting for its chance to attack the human body. Statistics indicate that the risk group for diabetes includes not...
Updated standards of diabetes treatment 2024
Recently, the American Diabetes Association (ADA) introduced updated recommendations for diabetes treatment standards in 2024, considering expert conclusions and new scientific discoveries. Last year, the standards focused on an individualized approach and advanced...
Uniting with the International Diabetes Federation to combat Type 2 diabetes
Recent events at the international level indicate growing attention to the issue of Type 2 diabetes (T2D) and the importance of raising awareness and advocacy in this field. Individuals with Type 2 diabetes (T2D) are partially subjected to stigma, often associated...
Partners
